The Mechanism Behind AOD-9604 Dosage Decisions AOD-9604 stimulates lipolysis and inhibits lipogenesis through beta-3 adrenergic receptor activation in adipose tissue, operating independently of the growth hormone receptor and IGF-1 axis
Through in-depth mechanistic research, particularly the quantitative understanding of the ferroptosis trigger threshold, and overcoming translational bottlenecks via AI-assisted drug discovery and advanced therapeutic nanodelivery systems, these natural products are expected to become important components of precision therapeutic strategies for sepsis in the future
Duration: 46 weeks post-PCT Dose: 2030 mcg/day for men, 1015 mcg/day for women Goal: Preserve lean mass, reduce catabolism, support hormonal rebound Nutrition and Supplement Support IGF-1 LR3 is powerful but its not magic
Results vary by individual, injury type, and treatment plan
Olasupo Odunsi, MD, Medical Director Reviewed July 5, 2026 Thinking about B12 shots but want to know if they actually deliver